S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › 0K9O › Research report
← 0K9O page
XStocksXray
Market X-Ray report · 19 October 2026

Nutanix, Inc. (0K9O)

London Exchange · UK · prices in USD · close of 19 Oct 2026

Key indicators

Last closeUSD 67.92
52-week range34.00 – 76.10
Return, 1 month / 3 months−2.9% / +26.3%
Return, 1 year / 3 years– / –
TrendAbove 200-day, below 50-day
RSI (14)43
Volatility (1 year)45.1%
Worst drawdown (1 year)-35.3%
Average daily value traded0.16M USD
Dividend yield–

Market X-Ray price-based

66/ 100 · Medium confidence · ahead of 78% of stocks on this exchange
Trend87
Momentum94
Stability (higher is calmer)36
Liquidity34
Income–

Five-year price chart navy: price · brown: 200-day average

32.3943.4454.4965.5576.602025-122026-022026-052026-072026-10

About the company

Nutanix is a software company that provides hyperconverged infrastructure, combining computing, storage and networking into integrated systems managed through its own software. Its platform runs enterprise applications and private cloud environments, and it also offers tools for managing workloads across private and public clouds. Customers are mainly large organisations and public institutions that need to modernise their data centres. The company is based in San Jose, California, in the United States.

On this site Nutanix, Inc. appears as a stock on the London Exchange (UK), code 0K9O, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Nutanix, Inc. (0K9O) trades on the London Exchange in UK. It last closed at USD 67.92 on 19 October 2026.

Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 840 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Nutanix, Inc. (0K9O)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend87 · StrongTrading above its long-term averages and near its highs.
Above 200-day average31.7%
From 52-week high-8.5%
Momentum94 · StrongRising faster than most stocks on this exchange.
3-month return26.3%
6-month return65.0%
12-month return, skipping the last month–
Stability (higher is calmer)36 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)45.1%
Worst drawdown, 1 year (smaller is calmer)-35.3%
Liquidity34 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.16M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−8.5%
1 month−2.9%
3 months+26.3%
6 months+65.0%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average68.67 / 51.59
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.40

Technical summary

DailyNeutral8 bullish · 1 neutral · 6 bearish
WeeklyStrongly bullish5 bullish · 1 neutral · 1 bearish
MonthlyStrongly bullish1 bullish · 0 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026